Glaukos Corporation
↗Aliso Viejo, USA
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is widely recognized for pioneering Micro-Invasive Glaucoma Surgery (MIGS), a category of procedures designed to lower intraocular pressure more safely and effectively than traditional invasive surgeries.
Beyond its leadership in MIGS, Glaukos has evolved into a multi-platform company with a robust portfolio of 'dropless' therapies. This includes sustained-release drug delivery systems like iDose TR and bio-activated pharmaceutical therapies for corneal health. The company is headquartered in Aliso Viejo, California, and maintains a global presence with research and manufacturing facilities across the United States.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$500M-$1B
Founded:1998
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$118M
Investors:Versant Ventures, Meritech Capital Partners, Domain Associates, InterWest Partners
STOCK
Exchange:NYSE
Ticker:GKOS
Market Cap:$6.9B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Medical Device, Small molecule, Sustained-release implant, Bio-activated pharmaceutical
Active Trials:14
Trial Phases:Phase 1: 3 | Phase 2: 5 | Phase 3: 4 | Phase 4: 2
FDA Approvals:5
EMA Approvals:2
CORPORATE STRUCTURE
Subsidiaries:Avedro, Inc., Dose Medical Corporation, Mobius Therapeutics
Key Partnerships:Radius XR (Wearable diagnostics), Topcon Healthcare (Digital diagnostics), Santen Pharmaceutical (PRESERFLO MicroShunt licensing), iVeena Delivery Systems (IVMED-80 licensing)
COMPETITION
Position:Leader
Competitors:Alcon, Bausch + Lomb, Sight Sciences, Ivantis, Nova Eye Medical
LEADERSHIP
Key Executives:
Thomas Burns - Chairman and CEO
Joseph Gilliam - President and COO
Alex Thurman - SVP and CFO
Scientific Founders:Richard L. Lindstrom, MD, M. Humayun, MD, PhD, Yossi Mandel, PhD
Board Members:William Link, Gilbert Kliman, Mark Foley, David Hoffmeister, Marc Stapley, Aimee Weisner
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Glaukos Corporation. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.